Filter Results :

Your search for Drug returned 2400 reports

Sort by


Global Systemic Lupus Erythematosus (SLE) Drugs Market 2015-2019

22 Apr 2015  |  Published by:  Technavio
About SLE SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system...

$ 3,000.00

Read More

Chromatography Resins Market in Drug Discovery by Technique (Ion Exchange, Affinity (Protein A, G & L), Hydrophobic Interaction, Size Exclusion, Multi Modal and Others) & Geography - Global Market Trends & Forecasts to 2020

17 Apr 2015  |  Published by:  MarketsandMarkets
Chromatography resins are used as stationary matrices in the chromatography column. The different techniques of chromatography are ion exchange, affinity, hydrophobic interaction, size exclusion, multi-modal, and others. The affinity chromatography is further sub-segmented into Protein A, Prot...

$ 4,650.00

Read More

Global Gastrointestinal OTC Drugs Market 2015-2019

15 Apr 2015  |  Published by:  Technavio
About gastrointestinal OTC drugs OTC drugs are medications that do not require a prescription. In contrast, prescription drugs can be sold only to consumers having a legal prescription. OTC drugs are carefully chosen by regulatory agencies to ensure their safety and efficacy. Gastrointestinal OTC dr...

$ 3,000.00

Read More

United States Off-Label Drugs Market & Forecast

13 Apr 2015  |  Published by:  Renub Research
“United States Off–Label Drugs Market & Forecast” report provides a comprehensive analysis of the emerging Off–Label Drugs market. The report also entails commonly prescribed Off–Label Drugs, Perspective of Physicians, Patients, Pharmaceutical Companies and Regulatory Authorities, Off–labe...

$ 1,200.00

Read More

Global Diabetes Drug Market & Pipeline Insight 2015

02 Apr 2015  |  Published by:  KuicK Research
Diabetes market is a rapidly growing segment with numerous products at different stages of clinical pipeline and others at different phases of industry life cycle. Disease incidences are escalating rapidly across the globe due to which high unmet demand has been created and pharmaceutical comp...

$ 2,400.00

Read More

Acute Bacterial Sinusitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Acute Bacterial Sinusitis-API Insights, 2015,report provides Acute Bacterial Sinusitis drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF fi...

$ 1,250.00

Read More

Substance (Drug) Abuse-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Substance (Drug) Abuse-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Substance (Drug) Abuse. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall under Substance ...

$ 1,250.00

Read More

Acute Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Acute Bronchitis-API Insights, 2015,report provides Acute Bronchitis drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00

Read More

Absence Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Absence Seizure-API Insights, 2015,report provides Absence Seizure drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide cou...

$ 1,250.00

Read More

Abscess-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Abscess-API Insights, 2015,report provides Abscess drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related t...

$ 1,250.00

Read More

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-API Insights, 2015,report provides Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the ...

$ 1,250.00

Read More

Actinic (Solar) Keratosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Actinic (Solar) Keratosis-API Insights, 2015,report provides Actinic (Solar) Keratosis drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF fi...

$ 1,250.00

Read More

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Acquired (Autoimmune) Hemolytic Anemia-API Insights, 2015,report provides Acquired (Autoimmune) Hemolytic Anemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File...

$ 1,250.00

Read More

Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Acne Vulgaris-API Insights, 2015,report provides Acne Vulgaris drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countri...

$ 1,250.00

Read More

Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Acid Indigestion / Heartburn/ Pyrosis-API Insights, 2015,report provides Acid Indigestion / Heartburn/ Pyrosis drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (...

$ 1,250.00

Read More
Total 2400 records.